AbbVie ABBV Cash Flow Statement (2012-2026)

NYSE ABBV
$266.55 +4.72 (+1.80%)
As of: Aug 21, 2026 · 11:05 AM EDT
Cash Flow Statement Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
3.18B4.04B4.49B0.93B3.95B2.47B-0.10B2.03B1.78B0.82B1.37B1.37B1.56B-0.02B1.29B0.94B0.19B1.81B0.70B3.62B
Depreciation and Depletion (Quarter)
0.22B0.17B0.20B0.20B0.18B0.20B0.18B0.19B0.20B0.19B0.18B0.18B0.19B0.21B0.18B0.19B0.19B0.20B0.19B0.19B
Share-based Compensation (Quarter)
0.14B0.13B0.31B0.11B0.13B0.13B0.31B0.18B0.13B0.12B0.35B0.22B0.18B0.16B0.41B0.18B0.21B0.16B0.44B0.17B
Deferred Taxes (Quarter)
-0.03B-0.74B-0.19B-0.60B-0.62B-0.52B-0.27B-0.37B-0.86B-1.39B-0.39B-0.02B-0.28B-0.77B-0.03B-0.27B0.19B-0.39B0.14B-0.20B
Gains from Investment Securities (Quarter)
0.10B0.23B-0.75B1.61B-0.21B2.11B1.87B1.55B0.01B1.70B0.66B1.48B1.36B0.28B1.52B2.79B0.78B1.41B2.39B1.52B
Asset Writedowns and Impairment (Quarter)
0.77B0.63B0.08B2.11B1.41B4.48B
Cash from Operations (Quarter)
7.93B5.08B4.91B5.00B7.60B7.43B4.19B6.32B7.57B4.75B4.04B2.27B5.45B7.05B1.64B5.15B7.02B5.22B3.83B3.44B
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
0.22B0.17B0.20B0.20B0.18B0.20B0.18B0.19B0.20B0.19B0.18B0.18B0.19B0.21B0.18B0.19B0.19B0.20B0.19B0.19B
Change in Working Capital
Change in Receivables (Quarter)
-0.59B0.75B0.79B0.61B-0.36B0.42B0.20B0.08B-0.00B-0.34B0.70B-0.18B-0.34B-0.39B1.48B0.02B0.16B-0.16B-0.09B1.37B
Change in Inventory (Quarter)
-0.22B0.11B0.39B0.11B0.02B0.17B0.18B0.27B0.06B-0.10B0.07B0.05B0.06B0.13B0.15B0.06B-0.00B0.03B0.18B0.14B
Change in Accured Expenses (Quarter)
1.15B0.27B-0.26B-0.19B0.94B1.28B-0.45B1.57B2.54B0.18B0.36B-1.70B0.27B1.25B-0.70B0.52B1.73B-0.60B-1.59B1.20B
Change in Taxes (Quarter)
-0.07B-0.66B0.44B-0.55B0.29B0.36B0.19B-1.12B0.03B0.41B0.38B-1.83B0.05B-1.80B0.38B-1.38B-0.41B0.65B-0.08B-2.22B
Other Working Capital Changes (Quarter)
0.18B-0.27B0.28B-0.30B0.07B0.20B0.17B-0.45B-0.11B0.58B-0.28B-0.03B-0.15B0.10B0.63B-0.37B-0.09B0.66B0.15B0.19B
Investing Activities
Capital Expenditures (Quarter)
0.22B0.19B0.16B0.14B0.18B0.21B0.17B0.18B0.22B0.20B0.19B0.24B0.25B0.29B0.23B0.27B0.38B0.33B0.27B0.32B
Acquisitions (Quarter)
0.53B9.20B8.29B0.20B
Change in Acquisitions & Divestments (Quarter)
0.02B0.01B0.01B0.04B1.41B0.07B0.02B0.01B0.01B0.01B0.01B0.00B0.51B0.04B0.03B0.01B0.00B0.03B
Cash from Investing Activities (Quarter)
-0.61B-1.15B-1.59B0.13B1.29B-0.45B-0.50B-0.34B-0.37B-0.80B-9.59B-1.10B-8.26B-1.87B-0.73B-1.18B-3.26B-1.46B-0.57B-1.20B
Financing Activities
Other financing activities (Quarter)
0.03B0.07B0.02B0.18B-0.16B-0.01B0.02B-0.00B0.13B0.03B0.13B-0.10B0.03B0.16B0.07B-0.01B0.01B0.10B0.00B0.03B
Cash from Financing Activities (Quarter)
-3.64B-6.34B-6.97B-2.68B-5.52B-9.63B-6.19B-3.92B-2.66B-4.45B10.82B-6.10B-3.07B-6.86B-1.26B-2.71B-4.59B-4.17B0.92B-5.05B
Dividend Payments
Dividends Paid - Common (Quarter)
2.31B2.31B2.53B2.51B2.50B2.51B2.66B2.62B2.63B2.63B2.77B2.75B2.75B2.75B2.92B2.91B2.91B2.91B3.09B3.07B
Additional items
Exchange Rate Effect (Quarter)
-0.04B-0.03B0.01B-0.03B-0.06B0.02B0.01B-0.01B-0.02B0.02B-0.02B-0.01B0.01B-0.05B0.01B0.03B-0.01B0.01B-0.01B-0.01B
Change in Cash (Quarter)
3.64B-2.44B-3.65B2.42B3.31B-2.63B-2.49B2.05B4.53B-0.47B5.25B-4.94B-5.87B-1.73B-0.35B1.29B-0.84B-0.40B4.16B-2.82B
Free Cash Flow (Quarter)
7.72B4.89B4.75B4.86B7.42B7.21B4.02B6.14B7.36B4.55B3.85B2.03B5.20B6.76B1.40B4.88B6.64B4.89B3.56B3.11B
Net Cash Flow (Quarter)
3.68B-2.41B-3.65B2.46B3.37B-2.65B-2.50B2.06B4.54B-0.50B5.27B-4.93B-5.88B-1.69B-0.36B1.26B-0.83B-0.41B4.17B-2.81B